Important safety information
LINQ family of insertable cardiac monitors (ICMs) systems and accessories

The Reveal LINQ™ ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:

patients with clinical syndromes or situations at increased risk of cardiac arrhythmias

patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain, that may suggest a cardiac arrhythmia

This device has not been tested specifically for pediatric use.

The LINQ II™ ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in adult patients, and in pediatric patients who are at least 2 years old, in the following cases:

patients with clinical syndromes or situations at increased risk of cardiac arrhythmias

patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia

Possible risks associated with the implant of a LINQ Family ICM (LINQ II ICM or Reveal LINQ ICM) include, but are not limited to, infection at the surgical site, device migration, erosion of the device through the skin and/or sensitivity to the device material. Accessories available for use with LINQ Family ICMs may experience connectivity or performance issues. See product manuals for details and troubleshooting instructions.

LINQ Family ICMs are prescribed by your physician and are not for everyone. Please talk to your doctor to see if it is right for you. Your physician should discuss all potential benefits and risks with you. Although many patients benefit from the use of this product, results may vary. For further information, please call the Medtronic toll-free number at 1-800-551-5544 (7:00 a.m. to 7:00 p.m., Monday-Friday, Central Time) or see the Medtronic website at www.medtronic.com.

MAJ_81012

Managing my AFib

Is long-term heart monitoring right for me?

Alert Important Safety Information

Taking blood thinners may not improve your AFib.¹

Understanding your treatment options can be confusing. There are common myths and misconceptions about the management of atrial fibrillation (AFib). It's important to educate yourself on AFib and your options for managing the condition.

Talk to your doctor about your symptoms and your options for managing your AFib.

Common AFib myths

Do you know your AFib burden?

AFib burden is the amount of time you are in AFib over a period of time.

Number of episodes (those you feel and those you do not feel)
How long your AFib episodes last

Once diagnosed with AFib, your doctor may have a difficult time getting the information he/she needs to understand if your AFib is under control.

Understanding your AFib burden can help your doctor determine which treatment options are right for you.

Medtronic insertable heart monitors can share valuable information with your doctor and may be able to help your doctor make decisions about medications and treatments such as blood thinners or ablation.^2-6

Read the brochure here to learn more.

Download and print the discussion guide to bring to your next doctor's appointment.

Discussion guide

A small, insertable heart monitor can help.

Many people living with AFib have experienced peace of mind with long-term heart monitoring. Long-term heart monitors, such as the LINQ II™ insertable heart monitor and the Reveal LINQ™ insertable heart monitor, send important information to your doctor to help him/her understand if your AFib has returned and how well your treatments are working.

Learn more

Patient Pam holding up a Reveal LINQ ICM

Josh's story

After being diagnosed with AFib, Josh received a Reveal LINQ insertable heart monitor. Thanks to the information shared by the heart monitor with his doctor, Josh was then able to have an ablation procedure.

This video represents an individual patient experience; results may vary.

References

Managing Atrial Fibrillation. StopAfib.org. Available at: stopafib.org/managing-afib/. Accessed August 11, 2022.

Witkowski M, Bissinger A, Grycewicz T, Lubinski A. Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker. Int J Cardiol. January 15, 2017;227:583-588.

Passman R, Leong-Sit P, Andrei AC, et al. Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study. J Cardiovasc Electrophysiol. March 2016;27(3):264-270.

⁴

Zuern CS, Kilias A, Berlitz P, et al. Anticoagulation after Catheter Ablation of Atrial Fibrillation Guided by Implantable Cardiac Monitors. Pacing Clin Electrophysiol. June 2015;38(6):688-693.

⁵

Mascarenhas DAN, Farooq MU, Ziegler PD, Kantharia BK. Role of insertable cardiac monitors in anticoagulation therapy in patients with atrial fibrillation at high risk of bleeding. Europace. June 2016;(18)6):799-806.

⁶

Pothineni NVK, Amankwah N, Santangeli P, et al. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation. J Cardiovasc Electrophysiol. February 2021;32(2):345-353.

Important safety information LINQ family of insertable cardiac monitors (ICMs) systems and accessories